Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Heme
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Heme

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

The color-furnishing portion of hemoglobin.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (690 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Ferroprotoporphyrin; Heme b; Protoheme; Protoheme IX; Haem.

Where it fits in the MeSH classification

Broader topics
Metalloporphyrins
Narrower topics
Hemin

Research landscape

PubMed indexes 23,927 records tagged with the MeSH heading “Heme” (counts retrieved 2026-10-31). 3,119 of them (13.0%) were published from 2020 onward, and the busiest period so far is through 1999 with 10,411 records.

Reviews account for 2,104 records (8.8%) and meta-analyses for 17. Randomized controlled trials number 72 (0.3%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 10,411 records; 2000-2009: 5,238 records; 2010-2019: 5,159 records; 2020 onward: 3,119 records10,411through 19995,2382000-20095,1592010-20193,1192020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199910,411
2000-20095,238
2010-20195,159
2020 onward3,119
Share of records by publication typeReviews: 8.8 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 0.3 percentReviews8.8% (2,104)Meta-analyses0.1% (17)Randomized controlled trials0.3% (72)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 23,927 PubMed records
TypeRecordsShare
Reviews2,1048.8%
Meta-analyses170.1%
Randomized controlled trials720.3%

Method: PubMed query "Heme"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Design of Heme Enzymes with a Tunable Substrate Binding Pocket Adjacent to an Open Metal Coordination Site
Kalvet I, Ortmayer M, Zhao J, Crawshaw R, Ennist NM, Levy C, et al.
2023Research article
Design not recorded in structured metadata
70cc by
PMID 37341421 · DOI · PMC10326885
Highly stable and tunable peptoid/hemin enzymatic mimetics with natural peroxidase-like activities
Jian T, Zhou Y, Wang P, Yang W, Mu P, Zhang X, et al.
2022Research article
Design not recorded in structured metadata
56cc by
PMID 35641490 · DOI · PMC9156750
Mitoferrin, Cellular and Mitochondrial Iron Homeostasis
Ali MY, Oliva CR, Flor S, Griguer CE
2022Review article
Design not recorded in structured metadata
52cc by
PMID 36359860 · DOI · PMC9658796
Proteasome-guided haem signalling axis contributes to T cell exhaustion
Xu Y, Shangguan Y, Chuang YM, Chang TH, Liu W, Peng JJ, et al.
2026Research article
Design not recorded in structured metadata
5cc by
PMID 41851457 · DOI · PMC13658038

Design of Heme Enzymes with a Tunable Substrate Binding Pocket Adjacent to an Open Metal Coordination Site [1]

Research article Kalvet I, Ortmayer M, Zhao J, Crawshaw R, Ennist NM, Levy C, et al. · · 2023 · cited 70 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The catalytic versatility of pentacoordinated iron is highlighted by the broad range of natural and engineered activities of heme enzymes such as cytochrome P450s, which position a porphyrin cofactor coordinating a central iron atom below an open substrate binding pocket.
Closing excerpt
Our approach now enables the custom design of enzymes containing cofactors adjacent to binding pockets with an almost unlimited variety of shapes and functionalities.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (227 words)

The catalytic versatility of pentacoordinated iron is highlighted by the broad range of natural and engineered activities of heme enzymes such as cytochrome P450s, which position a porphyrin cofactor coordinating a central iron atom below an open substrate binding pocket. This catalytic prowess has inspired efforts to design de novo helical bundle scaffolds that bind porphyrin cofactors. However, such designs lack the large open substrate binding pocket of P450s, and hence, the range of chemical transformations accessible is limited. Here, with the goal of combining the advantages of the P450 catalytic site geometry with the almost unlimited customizability of de novo protein design, we design a high-affinity heme-binding protein, dnHEM1, with an axial histidine ligand, a vacant coordination site for generating reactive intermediates, and a tunable distal pocket for substrate binding. A 1.6 Å X-ray crystal structure of dnHEM1 reveals excellent agreement to the design model with key features programmed as intended. The incorporation of distal pocket substitutions converted dnHEM1 into a proficient peroxidase with a stable neutral ferryl intermediate. In parallel, dnHEM1 was redesigned to generate enantiocomplementary carbene transferases for styrene cyclopropanation (up to 93% isolated yield, 5000 turnovers, 97:3 e.r.) by reconfiguring the distal pocket to accommodate calculated transition state models. Our approach now enables the custom design of enzymes containing cofactors adjacent to binding pockets with an almost unlimited variety of shapes and functionalities.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 37341421 · DOI · PMC10326885

Highly stable and tunable peptoid/hemin enzymatic mimetics with natural peroxidase-like activities [2]

Research article Jian T, Zhou Y, Wang P, Yang W, Mu P, Zhang X, et al. · · 2022 · cited 56 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Developing tunable and stable peroxidase mimetics with high catalytic efficiency provides a promising opportunity to improve and expand enzymatic catalysis in lignin depolymerization.
Closing excerpt
Because Pep/hemin catalysts are highly robust and tunable, we expect that they offer tremendous opportunities for lignin valorization to high value products.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (149 words)

Developing tunable and stable peroxidase mimetics with high catalytic efficiency provides a promising opportunity to improve and expand enzymatic catalysis in lignin depolymerization. A class of peptoid-based peroxidase mimetics with tunable catalytic activity and high stability is developed by constructing peptoids and hemins into self-assembled crystalline nanomaterials. By varying peptoid side chain chemistry to tailor the microenvironment of active sites, these self-assembled peptoid/hemin nanomaterials (Pep/hemin) exhibit highly modulable catalytic activities toward two lignin model substrates 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) and 3,3',5,5'-tetramethylbenzidine. Among them, a Pep/hemin complex containing the pyridyl side chain showed the best catalytic efficiency (Vmax/Km = 5.81 × 10-3 s-1). These Pep/hemin catalysts are highly stable; kinetics studies suggest that they follow a peroxidase-like mechanism. Moreover, they exhibit a high efficacy on depolymerization of a biorefinery lignin. Because Pep/hemin catalysts are highly robust and tunable, we expect that they offer tremendous opportunities for lignin valorization to high value products.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 35641490 · DOI · PMC9156750

Mitoferrin, Cellular and Mitochondrial Iron Homeostasis [3]

Review article Ali MY, Oliva CR, Flor S, Griguer CE · · 2022 · cited 52 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Iron is essential for many cellular processes, but cellular iron homeostasis must be maintained to ensure the balance of cellular signaling processes and prevent disease.
Closing excerpt
Here, we review the discovery and structure of the mitoferrins, as well as the significance of these proteins in maintaining cytosolic and mitochondrial iron homeostasis for the prevention of cancer and many other diseases.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (139 words)

Iron is essential for many cellular processes, but cellular iron homeostasis must be maintained to ensure the balance of cellular signaling processes and prevent disease. Iron transport in and out of the cell and cellular organelles is crucial in this regard. The transport of iron into the mitochondria is particularly important, as heme and the majority of iron-sulfur clusters are synthesized in this organelle. Iron is also required for the production of mitochondrial complexes that contain these iron-sulfur clusters and heme. As the principal iron importers in the mitochondria of human cells, the mitoferrins have emerged as critical regulators of cytosolic and mitochondrial iron homeostasis. Here, we review the discovery and structure of the mitoferrins, as well as the significance of these proteins in maintaining cytosolic and mitochondrial iron homeostasis for the prevention of cancer and many other diseases.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36359860 · DOI · PMC9658796

Proteasome-guided haem signalling axis contributes to T cell exhaustion [4]

Research article Xu Y, Shangguan Y, Chuang YM, Chang TH, Liu W, Peng JJ, et al. · · 2026 · cited 5 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The accumulation of depolarized mitochondria commits T cells to exhaustion1-3, yet the precise mechanism remains unclear.
Closing excerpt
Our findings identify a proteasome-guided haem signalling axis, governed by mitochondrial integrity, as a regulator of CD8+ T cell exhaustion and propose innovative therapeutic strategies that exploit this pathway to optimize adoptive cellular immunotherapy.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (175 words)

The accumulation of depolarized mitochondria commits T cells to exhaustion1-3, yet the precise mechanism remains unclear. Here we find that exhausted CD8+ T cells increase proteasome activity owing to the accumulation of depolarized mitochondria, which drives the selective degradation of mitochondrial proteins and the release of regulatory haem through haemoprotein breakdown. In turn, increased regulatory haem disrupts BACH2-mediated transcriptional regulation, thereby exacerbating T cell exhaustion and compromising stemness-like properties. Inhibition of nuclear import of regulatory haem prevents BACH2 degradation and enhances the anti-tumour efficacy of antigen-specific T cells. We find that the therapeutic efficacy of human CD19+ chimeric antigen receptor (CAR)-T cells in patients with B cell acute lymphoblastic leukaemia negatively correlates with the proteasome gene signature in their CAR-T cells. Manufacturing CAR-T cells in the presence of bortezomib, an FDA-approved proteasome inhibitor, prevents T cell exhaustion and improves therapeutic efficacy. Our findings identify a proteasome-guided haem signalling axis, governed by mitochondrial integrity, as a regulator of CD8+ T cell exhaustion and propose innovative therapeutic strategies that exploit this pathway to optimize adoptive cellular immunotherapy.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41851457 · DOI · PMC13658038

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Heme enzyme structure and function [5]
    Poulos TL · Chem Rev · 2014 · cited 900 times (Europe PMC)
  • Research article Macrophages and Iron Metabolism [6]
    Soares MP, Hamza I · Immunity · 2016 · cited 341 times (Europe PMC)
  • Research article Heme Synthesis and Acquisition in Bacterial Pathogens [7]
    Choby JE, Skaar EP · J Mol Biol · 2016 · cited 291 times (Europe PMC)
  • Research article Prokaryotic Heme Biosynthesis: Multiple Pathways to a Common Essential Product [8]
    Dailey HA, Dailey TA, Gerdes S, Jahn D, Jahn M, O'Brian MR, et al. · Microbiol Mol Biol Rev · 2017 · cited 271 times (Europe PMC)
  • Research article Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved [9]
    Bastide NM, Pierre FH, Corpet DE · Cancer Prev Res (Phila) · 2011 · cited 253 times (Europe PMC)
  • Research article Molecular Mechanisms of Iron and Heme Metabolism [10]
    Dutt S, Hamza I, Bartnikas TB · Annu Rev Nutr · 2022 · cited 250 times (Europe PMC)

References

  1. Kalvet I, Ortmayer M, Zhao J, Crawshaw R, Ennist NM, Levy C, et al.. Design of Heme Enzymes with a Tunable Substrate Binding Pocket Adjacent to an Open Metal Coordination Site. . 2023. PMID 37341421 · DOI · PMC10326885
  2. Jian T, Zhou Y, Wang P, Yang W, Mu P, Zhang X, et al.. Highly stable and tunable peptoid/hemin enzymatic mimetics with natural peroxidase-like activities. . 2022. PMID 35641490 · DOI · PMC9156750
  3. Ali MY, Oliva CR, Flor S, Griguer CE. Mitoferrin, Cellular and Mitochondrial Iron Homeostasis. . 2022. PMID 36359860 · DOI · PMC9658796
  4. Xu Y, Shangguan Y, Chuang YM, Chang TH, Liu W, Peng JJ, et al.. Proteasome-guided haem signalling axis contributes to T cell exhaustion. . 2026. PMID 41851457 · DOI · PMC13658038
  5. Poulos TL. Heme enzyme structure and function. Chem Rev. 2014. PMID 24400737 · DOI · PMC3981943
  6. Soares MP, Hamza I. Macrophages and Iron Metabolism. Immunity. 2016. PMID 26982356 · DOI · PMC4794998
  7. Choby JE, Skaar EP. Heme Synthesis and Acquisition in Bacterial Pathogens. J Mol Biol. 2016. PMID 27019298 · DOI · PMC5125930
  8. Dailey HA, Dailey TA, Gerdes S, Jahn D, Jahn M, O'Brian MR, et al.. Prokaryotic Heme Biosynthesis: Multiple Pathways to a Common Essential Product. Microbiol Mol Biol Rev. 2017. PMID 28123057 · DOI · PMC5312243
  9. Bastide NM, Pierre FH, Corpet DE. Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev Res (Phila). 2011. PMID 21209396 · DOI
  10. Dutt S, Hamza I, Bartnikas TB. Molecular Mechanisms of Iron and Heme Metabolism. Annu Rev Nutr. 2022. PMID 35508203 · DOI · PMC9398995

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • PorphyrinsDrugs and Chemicals
  • Chlorophyll ADrugs and Chemicals
  • Vitamin B 12Drugs and Chemicals
  • AcetazolamideDrugs and Chemicals
  • AminopyrineDrugs and Chemicals
  • AnastrozoleDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

23,927
PubMed records on this heading
13%
published since 2020
2,104
review articles
72
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • PorphyrinsDrugs and Chemicals
  • Chlorophyll ADrugs and Chemicals
  • Vitamin B 12Drugs and Chemicals
  • AcetazolamideDrugs and Chemicals
  • AminopyrineDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support